Results 1 to 10 of about 816,372 (304)
Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. [PDF]
IEEE J Sel Top Quantum Electron, 2016 Photobiomodulation (PBM) also known as low-level laser (or light) therapy (LLLT), has been known for almost 50 years but still has not gained widespread acceptance, largely due to uncertainty about the molecular, cellular, and tissular mechanisms of action.
de Freitas LF, Hamblin MR.
europepmc +6 more sources
Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia.
J Cutan Aesthet Surg, 2021 Androgenetic alopecia (AGA) is the commonest type of alopecia affecting over half of men and women. Only two drugs have been approved so far (minoxidil and finasteride), and hair transplant is the other treatment alternative. Low-level laser therapy (LLLT) has been claimed to be a new safe devise-based modality for stimulating hair growth in men and ...
Pillai JK, Mysore V.
europepmc +5 more sources
Biphasic Dose Response in Low Level Light Therapy – an Update [PDF]
Dose-Response, 2011 Low-level laser (light) therapy (LLLT) has been known since 1967 but still remains controversial due to incomplete understanding of the basic mechanisms and the selection of inappropriate dosimetric parameters that led to negative studies.
Ying-Ying Huang +3 more
doaj +5 more sources
Low-level light therapy of the eye and brain [PDF]
Eye and Brain, 2011 Julio C Rojas1,2, F Gonzalez-Lima1 1Departments of Psychology, Pharmacology and Toxicology, University of Texas at Austin, Austin, TX; 2Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA ...
Rojas JC, Gonzalez-Lima F
doaj +6 more sources
Assessment of effects of low-level light therapy on scalp condition and hair growth
Indian Journal of Dermatology, 2023 Background: The appearance of the scalp and hair is very important aesthetically regardless of age or sex. Although there are many drugs and treatment methods for scalp problems and hair loss, the treatment response is still insufficient.
Jin Hee Kim +4 more
doaj +3 more sources
Biphasic Dose Response in Low Level Light Therapy
Dose-Response, 2009 The use of low levels of visible or near infrared light for reducing pain, inflammation and edema, promoting healing of wounds, deeper tissues and nerves, and preventing cell death and tissue damage has been known for over forty years since the invention
Ying-Ying Huang +3 more
doaj +4 more sources
Low-Level Light Therapy in Association with Intense Pulsed Light for Meibomian Gland Dysfunction [PDF]
Clinical Ophthalmology, 2022 João Heitor Marques,1 Ana Marta,1,2 Pedro Manuel Baptista,1,2 Daniel Almeida,1 Diana José,1 Paulo JM Sousa,1 Irene Barbosa1,2 1Ophthalmology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal; 2Instituto de Ciências Biomédicas Abel ...
Marques JH +6 more
doaj +3 more sources
Effects of low-level light therapy on dentin hypersensitivity: a systematic review and meta-analysis. [PDF]
Clin Oral Investig, 2021 To investigate the treatment efficacy of low-level light therapy on dentin hypersensitivity. Following the PRISMA guideline, six electronic databases supplemented with bibliographies were searched till December 2020.
Shan Z +5 more
europepmc +4 more sources
Photobiomodulation (low-level light therapy) and dry eye disease
Clinical and Experimental Optometry, 2021 Dry eye disease is one of the most common, chief-complaints presenting in clinical practice, with a prevalence of up to 50%. Evaporative dry eye, as a result of meibomian gland dysfunction, is thought to be the biggest component factor. Treatments for meibomian gland dysfunction aim to restore tear film homoeostasis and include warm compress therapy ...
Markoulli, M, Chandramohan, N, Papas, EB
semanticscholar +6 more sources
Low level light therapy/photobiomodulation for diabetic peripheral neuropathy: protocol of a systematic review and meta-analysis. [PDF]
BMJ Open, 2022 Introduction Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes that strongly impact the patients’ quality of life and working ability.
Wang JY +7 more
europepmc +4 more sources